We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

A 1-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a 2-dose program.

Cancer vaccines train the immune system to combat foreign invaders like tumours, enhancing the body's ability to recognize ...

IN Menopause Awareness Month, it’s great to see more celebrities talk about their experiences. It reminds women they are not alone if, and when, symptoms occur. The best way to prepare for ...

A new chemotherapy regimen significantly boosts survival rates in cervical cancer patients and reduces the risk of death by ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is hindered by its production ...

Oncologists are increasingly looking to oral sex as a primary driver of a steady rise in throat cancers. Rates of the disease ...

The enrollment for the mRNA cancer vaccine for the treatment of squamous cell skin carcinoma has started at the Pascale ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?